Dhruva Biswas

5.5k total citations
20 papers, 322 citations indexed

About

Dhruva Biswas is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Immunology. According to data from OpenAlex, Dhruva Biswas has authored 20 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in Dhruva Biswas's work include Cancer Immunotherapy and Biomarkers (6 papers), ECG Monitoring and Analysis (3 papers) and Cardiovascular Function and Risk Factors (3 papers). Dhruva Biswas is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), ECG Monitoring and Analysis (3 papers) and Cardiovascular Function and Risk Factors (3 papers). Dhruva Biswas collaborates with scholars based in United Kingdom, United States and Netherlands. Dhruva Biswas's co-authors include Yin Wu, Richard Woolf, Adrian Hayday, Cristina Naceur‐Lombardelli, Andrew Tutt, Patrycja Gazińska, Anna Lorenc, Anita Grigoriadis, Julie Owen and Pierre Vantourout and has published in prestigious journals such as Circulation, Nature Communications and Journal of the American College of Cardiology.

In The Last Decade

Dhruva Biswas

18 papers receiving 315 citations

Peers

Countries citing papers authored by Dhruva Biswas

Since Specialization

Citations

This map shows the geographic impact of Dhruva Biswas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dhruva Biswas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dhruva Biswas more than expected).

Fields of papers citing papers by Dhruva Biswas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dhruva Biswas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dhruva Biswas. The network helps show where Dhruva Biswas may publish in the future.

Co-authorship network of co-authors of Dhruva Biswas

This figure shows the co-authorship network connecting the top 25 collaborators of Dhruva Biswas. A scholar is included among the top collaborators of Dhruva Biswas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dhruva Biswas. Dhruva Biswas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and Multinational Validation of Artificial Intelligence-Enabled ASCVD Risk Stratification Using Electrocardiograms 2026 ·medRxiv ·(unknown), (unknown), (unknown), Arya Aminorroaya, Dhruva Biswas, (unknown), (unknown), (unknown), (unknown), (unknown)	0
2	Transforming Population Health Screening for Atherosclerotic Cardiovascular Disease with AI-Enhanced ECG Analytics: Opportunities and Challenges 2025 ·Current Atherosclerosis Reports ·Dhruva Biswas, Arya Aminorroaya, (unknown), (unknown), (unknown), Rohan Khera	2
3	Harnessing Artificial Intelligence for Innovation in Interventional Cardiovascular Care 2025 ·Journal of the Society for Cardiovascular Angiography & Interventions ·Arya Aminorroaya, Dhruva Biswas, (unknown), Rohan Khera	3
4	Artificial Intelligence for Cardiovascular Care in Action 2025 ·JACC Advances ·Dhruva Biswas, Phyllis Thangaraj, (unknown), Modele O. Ogunniyi, Thomas M. Maddox, Faraz S. Ahmad, Rohan Khera	0
5	Effects of Tirzepatide in Type 2 Diabetes 2025 ·Journal of the American College of Cardiology ·Arya Aminorroaya, Evangelos K. Oikonomou, Dhruva Biswas, Ania M. Jastreboff, Rohan Khera	1
6	Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanoma 2025 ·Journal for ImmunoTherapy of Cancer ·Zena Willsmore, Lucy H. Booth, Akshay J. Patel, Ashley Di Meo, Ioannis Prassas, Jitesh Chauhan, Yin Wu, (unknown), (unknown), (unknown), Dhruva Biswas, Esperanza Perucha, Sean Whittaker, Sophia Tsoka, Eleftherios P. Diamandis, Gary Middleton, Thomas J Tull, Sophie Papa, Katie E. Lacy, Sophia N. Karagiannis	2
7	Phenotypic Selectivity of Artificial Intelligence–Enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction 2025 ·Circulation ·(unknown), Lovedeep Singh Dhingra, Dhruva Biswas, Evangelos K. Oikonomou, Rohan Khera	2
8	PD-1 defines a distinct, functional, tissue-adapted state in Vδ1+ T cells with implications for cancer immunotherapy 2024 ·Nature Cancer ·Daniel Davies, Shraddha Kamdar, Richard Woolf, Iva Zlatareva, Maria Luisa Iannitto, (unknown), Yasmin Haque, (unknown), Dhruva Biswas, (unknown), (unknown), Cheryl Gillett, Olga O’Neill, Oliver Nussbaumer, Adrian Hayday, Yin Wu	25
9	Cancer cell – Fibroblast crosstalk via HB-EGF, EGFR, and MAPK signaling promotes the expression of macrophage chemo-attractants in squamous cell carcinoma 2024 ·iScience ·(unknown), Antonio Rullan, Yutaka Naito, Dhruva Biswas, (unknown), Steven Hooper, Pablo Nenclares, Shreerang Bhide, Maggie C.U. Cheang, Probir Chakravarty, Eishu Hirata, Charles Swanton, Alan Melcher, Kevin J. Harrington, Erik Sahai	4
10	Race- and Ethnicity-Related Differences in Heart Failure With Preserved Ejection Fraction Using Natural Language Processing 2024 ·JACC Advances ·(unknown), Dhruva Biswas, Jack Wu, M. J. Ryan, (unknown), (unknown), (unknown), Ranu Baral, Antonio Cannatà, Thomas Searle, Narbeh Melikian, Daniel Sado, Thomas F. Lüscher, James Teo, Richard Dobson, Daniel I. Bromage, Theresa A. McDonagh, Ali Vazir, Ajay M. Shah, Kevin O’Gallagher	3
11	Quantifying the impact of immunotherapy on RNA dynamics in cancer 2023 ·Journal for ImmunoTherapy of Cancer ·Ieva Usaite, Dhruva Biswas, Krijn K. Dijkstra, Thomas B.K. Watkins, Oriol Pich, Clare Puttick, Mihaela Angelova, Krupa Thakkar, Crispin T. Hiley, Nicolai J. Birkbak, Marleen Kok, Simone Zaccaria, Yin Wu, Kevin Litchfield, Charles Swanton, Nnennaya Kanu	2
12	Using natural language processing to generate a large-scale database of aortic stenosis with long-term follow-up: the CASPER (cogstack aortic stenosis patient electronic registry) database 2023 ·European Heart Journal ·(unknown), Dhruva Biswas, (unknown), (unknown), (unknown), Gerry Kaye, Richard Dobson, Phil Chowienczyk, Ajay M. Shah, Kevin O’Gallagher	2
13	Artificial Intelligence Methods for Improved Detection of Undiagnosed Heart Failure with Preserved Ejection Fraction 2023 ·European Journal of Heart Failure ·Jack Wu, Dhruva Biswas, M. J. Ryan, (unknown), (unknown), (unknown), (unknown), Ranu Baral, Thomas Searle, Narbeh Melikian, Daniel Sado, Thomas F. Lüscher, Richard Grocott‐Mason, Gerald Carr‐White, James Teo, Richard Dobson, Daniel I. Bromage, Theresa A. McDonagh, Ajay M. Shah, Kevin O’Gallagher	27
14	RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma 2022 ·Nature Communications ·Philip East, Gavin Kelly, Dhruva Biswas, Michela Marani, David C. Hancock, Todd Creasy, Kris F. Sachsenmeier, Charles Swanton, Julian Downward, Sophie de Carné Trécesson	16
15	Impact of cancer evolution on immune surveillance and checkpoint inhibitor response 2021 ·Seminars in Cancer Biology ·Yin Wu, Dhruva Biswas, Charles Swanton	27
16	An innate-like Vδ1 ⁺ γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancer 2019 ·Science Translational Medicine ·Yin Wu, (unknown), Richard Woolf, Cristina Naceur‐Lombardelli, Julie Owen, Dhruva Biswas, Anna Lorenc, Pierre Vantourout, Patrycja Gazińska, Anita Grigoriadis, Andrew Tutt, Adrian Hayday	139
17	Anti-allergic activity of German chamomile (Matricaria recutita L.) in mast cell mediated allergy model 2011 ·Journal of Ethnopharmacology ·Chandrashekhar V. Mangannavar, (unknown), (unknown), (unknown), (unknown), Dhruva Biswas, Iranna S. Muchchandi	61
18	Management of carcinoma showing thymus-like element 2010 ·The Journal of Laryngology & Otology ·Dhruva Biswas, (unknown), Stephen L. Atkin, R England	1
19	Accelerated hypofractionated radiotherapy for non small cell lung cancer: Pooled results from 4 UK centres 2010 ·Lung Cancer ·Omar Din, Susan Harden, (unknown), N. Mohammed, L. Pemberton, J.F. Lester, Dhruva Biswas, L. Magee, Adnan Tufail, Ross Carruthers, (unknown), David Gilligan, M. Hatton	4
20	Radical radiotherapy for non small cell lung cancer 2009 ·Lung Cancer ·Dhruva Biswas, (unknown), David Gilligan, Susan Harden	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact